MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6230-6238

  Nishimura, Michael I ^a   Avichezer, Dody ^a   Custer, Mary C ^a   Lee, Catherine S ^a   Chen, Christine ^a   Parkhurst, Maria R ^a   Diamond, Rochelle A ^b   Robbins, Paul F ^a   Schwartzentruber, Douglas J ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; TUMOR CELLS, CULTURED;

EID: 0033572502     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Rothenberg, E. V. The development of functionally responsive T cells. Adv. Immunol., 51: 85-214, 1992.
2. Aguila, H. L., Akashi, K., Domen, J., Gandy, K. L., Lagasse, E., Mebius, R. E., Morrison, S. J., Shizuru, J., Strober, S., Uchida, N., Wright, D. E., and Weissman, I. L. From stem cells to lymphocytes: biology and transplantation. Immunol. Rev., 157: 13-40, 1997.
3. Zinkemagel, R. M., and Doherty, P. C. The discovery of MHC restriction. Immunol. Today, 18: 14-17, 1997.
4. Sprent, J., Schaefer, M., Lo, D., and Korngold, R. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo. Immunol. Rev., 91: 195 1986.
5. Swain, S. L. T cell subsets and the recognition of MHC class. Immunol. Rev., 74: 129-142, 1983.
6. Wucherpfennig, K. W., and Strominger, J. L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell, 80: 695-705, 1995.
7. Oldstone, M. B. Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease. Curr. Top. Microbiol. Immunol., 145: 127-135, 1989.
8. Ashton-Rickardt, P. G., Van Kaer, L., Schumacher, T. N., Ploegh, H. L., and Tonegawa, S. Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell, 73: 1041-1049, 1993.
9. Hogquist, K. A., and Bevan, M. J. The nature of the peptide/MHC ligand involved in positive selection. Semin. Immunol., 8: 63-68, 1996.
10. Hogquist, K. A., Gavin, M. A., and Bevan, M. J. Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J. Exp. Med., 177: 1469-1473, 1993.
11. Wilson, D. B., Blyth, J. L., and Nowell, P. C. Quantitative studies on the mixed lymphocyte interaction in rats. III. Kinetics of the response. J. Exp. Med., 128: 1157-1181, 1968.
12. Loftus, D. J., Castelli, C., Clay, T. M., Squarcina, P., Marincola, F. M., Nishimura, M. I., Parmiani, G., Appella, E., and Rivoltini, L. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35). J. Exp. Med., 184: 647-657, 1996.
13. Hiemstra, H. S., van Veelen, P. A., Schloot, N. C., Geluk, A., van Meijgaarden, K. E., Willemen, S. J., Leunissen, J. A., Benckhuijsen, W. E., Amons, R., de Vries, R. R., Roep, B. O., Ottenhoff, T. H., and Drijfhout, J. W. Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries. J. Immunol., 161: 4078-4082, 1998.
14. Evavold, B. D., Sloan-Lancaster, J., Wilson, K. J., Rothbard, J. B., and Allen, P. M. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity, 2: 655-663, 1995.
15. Topalian, S. L., Solomon, D., and Rosenberg, S. A. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142: 3714-3725, 1989.
16. Topalian, S. L., Rivoltini, L., Mancini, M., Ng, J., Hartzman, R. J., and Rosenberg, S. A. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer, 58: 69-79, 1994.
17. Bright, R. K., Vocke, C. D., Emmert-Buck, M. R., Duray, P. H., Solomon, D., Fetsch, P., Rhim, J. S., Linehan, W. M., and Topalian, S. L. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res., 57: 995-1002, 1997.
18. Anglard, P., Trahan, E., Liu, S., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B., and Linehan, W. M. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res., 52: 348-356, 1992.
19. Schrump, D. S., Chen, G. A., Consuli, U., Jin, X., and Roth, J. A. Inhibition of esophageal cancer proliferation by adenovirally mediated delivery of p16INK4. Cancer Gene Ther. 3: 357-364, 1996.
20. Rivoltini, L., Barracchini, K. C., Viggiano, V., Kawakami, Y., Smith, A., Mixon, A., Restifo, N. P., Topalian, S. L., Simonis, T. B., and Rosenberg, S. A. Quantitative correlation between HLA class 1 allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res., 55: 3149-3157, 1995.
21. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
22. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
23. Clay, T. M., Custer, M. C., McKee, M. D., Parkhurst, M., Robbins, P. F., Kerstann, K., Wunderlich, J., Rosenberg, S. A., and Nishimura, M. I. Changes in the fine specificity of gp100 (209-217) reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.I anchor residue. J. Immunol., 162: 1749-1755, 1999.
24. Robbins, P. F., El-Gamil, M., Kawakami, Y., Stevens, E., Yannelli, J. R., and Rosenberg, S. A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54: 3124-3126, 1994.
25. Pieper, R., Christian, R. E., Gonzales, M. I., Nishimura, M. I., Gupta, G., Settlage, R. E., Shabanowita, J., Rosenberg, S. A., Hunt, D. F., and Topalian, S. L. Biochemical identification of a mutated human melanoma antigen recognized by CD4+ T cells. J. Exp. Med., 189: 757-765, 1998.
26. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6464, 1994.
27. Wang, R. F., Appella, E., Kawakami, Y., Kang, X., and Rosenberg, S. A. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med., 184: 2207-2216, 1996.
28. Wang, R. F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., and Rosenberg, S. A. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J. Immunol., 161: 3598-3606, 1998.
29. Parkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, A., Rosenberg, S. A., and Kawakami, Y. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J. Immunol., 157: 2539-2548, 1996.
30. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154: 3961-3968, 1995.
31. Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K. H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759-764, 1994.
32. Skipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard, V., Van Pel, A., Chen., Y., Shabanowitz, J., Wolfel, T., Slingluff, C. L., Boon, T., Hunt, D. F., and Engelhard, V. H. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modificalion and suggests a novel pathway for processing of membrane proteins. J. Exp. Med., 183: 527-534, 1996.
33. del Guercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T., and Sette, A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol., 154: 685-693, 1995.
34. Nishimura, M. I., Kawakami, Y., Charmley, P., O'Neil, B., Shilyansky, J., Yannelli, J. R., Rosenberg, S. A., and Hood, L. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines. J. Immunother., 16: 85-94, 1994.
35. Rowen, L., Koop, B. F., and Hood, L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science (Washington DC), 272: 1755-1762, 1996.
36. WHO. Nomenclature for T-cell receptor (TCR) gene segments of the immune system. WHO-IUIS Nomenclature Sub-Committee on TCR Designation. Immunogenetics, 42: 451-453, 1995.
37. Deveraux, J., Haeberli, P., and Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res., 12: 387-395, 1984.
38. Schwartzentruber, D. J., Topalian, S. L., Mancini, M., and Rosenberg, S. A. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-α, and IFN-γ by human tumor-infiltrating lymphocytes after autologous tumor stimulation. J. Immunol., 146: 3674-3681, 1991.
39. Robbins, P. F., El-Gamil, M., Li, Y. F., Topalian, S. L., Rivoltini, L., Sakaguchi, K., Appella, E., Kawakami, Y., and Rosenberg, S. A. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J. Immunol., 154: 5944-5950, 1995.
40. Darrow, T. L., Abdel-Wahab, Z., Quinn-Allen, M. A., and Seigler, H. F. Recognition and lysis of human melanoma by a CD3+, CD44+, CD8-T-cell clone restricted by HLA-A2. Cell. Immunol., 172: 52-59, 1996.
41. Jacob, L., Somasundaram, R., Smith, W., Monos, D., Basak, S., Marincola, F., Pereira, S., and Herlyn, D. Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. Int. J. Cancer, 71: 325-332, 1997.
42. LeMay, L. G., Kan-Mitchell, J., Goedegebuure, P., Harel, W., and Mitchell, M. S. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma. Cancer Immunol. Immunother., 17: 187-194, 1993.
43. Kharkevitch, D. D., Seito, D., Balch, G. C., Maeda, T., Balch, C. M., and Itoh, K. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int. J. Cancer, 58: 317-323, 1994.
44. Hayashi, Y., Hoon, D. S., Park, M. S., Terasaki, P. I., Foshag, L. J., and Morton, D. L. Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A. Cell. Immunol., 139: 411-425, 1992.
45. - T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC). Int. J. Cancer. 51: 962-967, 1992.
46. Meadows, L., Wang, W., den Haan, J. M., Blokland, E., Reinhardus, C., Drijfhout, J. W., Shabanowitz, J., Pierce, R., Agulnik, A. I., Bishop, C. E., Hunt, D. F., Goulmy, E., and Engelhard, V. H. The HLA-A*0201-restricted H-Y antigen contains a post-translationally modified cysteine that significantly affects T cell recognition. Immunity, 6: 273-281, 1997.
47. Fink, P. J., and Bevan, M. J. H-2 antigens of the thymus determine lymphocyte specificity. J. Exp. Med., 148: 766-775, 1978.
48. Ashton-Rickardt, P. G., Van Kaer, L., Schumacher, T. N. M., Ploegh, H. L., and Tonegawa, S. Repertoire-determining role of peptide in the positive selection of CD8+ T cells. Immunol. Rev., 135: 157-182, 1993.
49. Bouchard, B., Fuller, B. B., Vijayasaradhi, S., and Houghton, A. N. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med., 169: 2029-2042, 1989.
50. Sensi, M., and Parmiani, G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today, 16: 588-595, 1995.
51. Shilyansky, J., Nishimura, M. I., Yannelli, J. R., Kawakami, Y., Jacknin, L. S., Charmley, P., and Rosenberg, S. A. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc. Natl. Acad. Sci. USA. 91: 2829-2833, 1994.
52. Cole, D. J., Weil, D. P., Shamamian, P., Rivoltini, L., Kawakami, Y., Topalian, S., Jennings, C., Eliyahu, S., Rosenberg, S. A., and Nishimura, M. I. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res., 54: 5265-5268, 1994.
53. Shinohara, N., and Sachs, D. H. Mouse alloantibodies capable of blocking cytotoxic T-cell function. J. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus. J. Exp. Med., 150: 432-444, 1979.
54. Robey, E., Ramsdell, F., Elliott, J., Raulet, D., Kioussis, D., Axel, R., and Fowlkes, B. J. Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 88: 608-612, 1991.
55. Cammarota, G., Scheirle, A., Takacs, B., Doran, D. M., Knorr, R., Bannwarth, W., Guardiola, J., and Sinigaglia, F. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature (Lond.), 356: 799-801, 1992.
56. Salter, R. D., Benjamin, R. J., Wesley, P. K., Buxton, S. E., Garrett, T. P., Clayberger, C., Krensky, A. M., Norment, A. M., Littman, D. R., and Parham, P. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature (Lond.), 345: 41-46, 1990.
57. Garcia, K. C., Scott, C. A., Brunmark, A., Carbone, F. R., Peterson, P. A., Wilson, I. A., and Teyton, L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature (Lond.), 384: 577-581, 1996.
58. Doyle, C., and Strominger, J. L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature (Lond.), 330: 256-259, 1987.
59. Veillette, A., Bookman, M. A., Horak, E. M., and Bolen, J. B. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell, 55, 301-308, 1988.
60. MacDonald, H. R., Glasebrook, A. L., Acuto, O., Kelso, A., Bron, C., and Cerottini, J. C. Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion. Adv. Exp. Med. Biol., 146: 533-545, 1982.
61. Malissen, B., Rebai, N., Liabeuf, A., and Mawas, C. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. Immunol., 12: 739-747, 1982.
62. Shimonkevitz, R., Luescher, B., Cerottini, J. C., and MacDonald, H. R. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. J. Immunol., 135: 892-899, 1985.
63. Cole, D. J., Weil, D. P., Shilyansky, J., Custer, M., Kawakami, Y., Rosenberg, S. A., and Nishimura, M. I. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res., 55: 748-752, 1995.
64. Gabert, J., Langlet, C., Zamoyska, R., Parnes, J. R., Schmitt-Verhulst, A. M., and Malissen, B. Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes. Cell, 50: 545-554, 1987.
65. Clay, T. M., Custer, M. C., Sachs, J. A., Rosenberg, S. A., and Nishimura, M. I. Efficient transfer of a tumor antigen-reactive TcR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol., 163: 507-513, 1999.
66. Alexander-Miller, M. A., Leggatt, G. R., and Berzofsky, J. A. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA, 93: 4102-4107, 1996.